The European Commission revokes the approval of the drug against CBP
Revocation of the authorisation of obetycholic acid for the treatment of primary biliary cholangitis (CBP)
The recent decision by the European Commission to withdraw marketing authorisation for obeticlic acid for the treatment of primary…